MedTrace Logo

AI for Onsite Cytology Evaluation in Endoscopic Ultrasound

NCT07228689 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-14

No results posted yet for this study

Summary

The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.

Conditions

  • Gastrointestinal Neoplasm
  • Mass Lesion

Interventions

DIAGNOSTIC_TEST

EUS-guided fine needle biopsy

EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract

Sponsors & Collaborators

  • Orlando Health, Inc.

    lead OTHER

Principal Investigators

  • Ji Young Bang, MD MPH · Orlando Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-12
Primary Completion
2026-12-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07228689 on ClinicalTrials.gov